Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Controversy over the F.D.A.'s proposal to withdraw approval of Avastin for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds.

18 Jun 2011

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer.

18 Jun 2011

OptumHealth names Women & Infants as Center of Excellence for Reproductive Resource Services

Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.

18 Jun 2011

Adolescent obese males at risk of cancer later in life: Study

According to a new study, men who are obese as teenagers are at a greater risk of cancer. Researchers claim that the risk remains even among those who lose weight later in life.

17 Jun 2011

Cancer vaccine shows promise

In the latest research news, a cervical cancer vaccine programme has produced the first evidence of disease prevention among treated women. This vaccine targets human papillomavirus (HPV), the virus believed to trigger cervical cancer in women.

17 Jun 2011

RHEI receives Chinese SFDA acceptance letter for MuGard

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, RHEI Pharmaceuticals has received the acceptance letter from the State Food and Drug Administration (SFDA) of China acknowledging all necessary documentation for the MuGard has been submitted and accepted.

17 Jun 2011

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

17 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

Loyola employee donates kidney to complete stranger, saves her own life

When Dorothy Jambrosek, 47, decided to donate a kidney to a stranger, she didn't realize that her goodwill would save her own life. After undergoing a series of tests required to give a kidney, doctors discovered that Jambrosek had precancerous lesions in her breast that could become cancerous.

17 Jun 2011

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.

17 Jun 2011

Roche RTCA HT Instrument allows fully-automated impedance screens for GPCRs

Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.

17 Jun 2011

CTI announces positive results from Phase I-II pixantrone combination study against INHL

Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.

17 Jun 2011

Experimental vaccine shows promise for patients with newly diagnosed brain tumors

An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.

17 Jun 2011

Transgenomic introduces Nuclear Mitome Test for diagnosis of mitochondrial disorders

Transgenomic, Inc. today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.

16 Jun 2011

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

UK based Global Clinical Research Organisation (CRO), ClinTec International has continued its international expansion by opening fully registered offices in China, Singapore and Thailand - consolidating its presence in the Asia Pacific region.

16 Jun 2011

Music and drama therapy improve physical, emotional components of Parkinson's

Twice a month a jam session takes place on the third floor of Northwestern Memorial's Prentice Women's Hospital. A diverse group of men and women, ranging in age and ethnicity, gather in a circle with instruments in hand and sing together. This is no ordinary jam band; all its members have Parkinson's disease.

16 Jun 2011

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

A new study from Rhode Island Hospital has found that MR enterography (MRE) without the use of an anti-peristaltic agent were as reliable as CT enterography (CTE) in determining the presence of Crohn's disease.

16 Jun 2011

Oncology News and Research

Further Reading

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

OptumHealth names Women & Infants as Center of Excellence for Reproductive Resource Services

Adolescent obese males at risk of cancer later in life: Study

Cancer vaccine shows promise

RHEI receives Chinese SFDA acceptance letter for MuGard

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Loyola employee donates kidney to complete stranger, saves her own life

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Roche RTCA HT Instrument allows fully-automated impedance screens for GPCRs

CTI announces positive results from Phase I-II pixantrone combination study against INHL

Experimental vaccine shows promise for patients with newly diagnosed brain tumors

Transgenomic introduces Nuclear Mitome Test for diagnosis of mitochondrial disorders

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Adaptimmune melanoma trial opening

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

Music and drama therapy improve physical, emotional components of Parkinson's

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News